Author

Laszlo Gulacsi 1

1 Covin

COST-UTILITY OF BIOSIMILAR INFLIXIMAB (INFLECTRA©) FOR THE TREATMENT OF LUMINAL CROHN?S DISEASE IN NINE EUROPEAN COUNTRIES

Fanni Rencz, Valentin Brodszky, Petra Baji, Marta Pentek, Laszlo Gulacsi, Petra Anna Golovics, Zsuzsanna Vegh, Krisztina Barbara Gecse, Silvio Danese, Peter Irving, Peter L Lakatos

COST-UTILITY OF BIOSIMILAR INFLIXIMAB FOR THE TREATMENT OF FISTULISING CROHN?S DISEASE IN NINE EUROPEAN COUNTRIES

Petra Baji, Marta Pentek, Valentin Brodszky, Laszlo Gulacsi, Fanni Rencz, Petra Anna Golovics, Krisztina Barbara Gecse, Zsuzsanna Vegh, Silvio Danese, Peter Irving, Peter L Lakatos

Going Above and Beyond: A Full Spectrum of Innovation for Personalized, Convenient, and Affordable Treatment (CELLTRION HEALTHCARE)

Walter Reinisch, Laszlo Gulacsi

WORK DISABILITY AND PRODUCTIVITY LOSS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN HUNGARY IN THE ERA OF BIOLOGICS

Anita Balint, Michael Mandel, Petra Anna Golovics, Laszlo Gulacsi, Bálint Strbák, Klaudia Farkas, Zsuzsanna Kürti, Blanka Krisztina Szilagyi, Anna Mohas, Tamás Molnár, Peter L Lakatos

Item 1 - 4 / 4
1